Neonatal Biomarkers Study (NBS)

AddtoAny
Share:

WATCH THIS PAGE

Subscribe to be notified of changes or updates to this page.

2 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

This pilot study is investigating the feasibility of a prospective biomarker study in the CICU by measuring enrollment of subjects, as well as the looking at outcomes. The goal of this study is to risk stratify neonates with congenital heart disease requiring neonatal cardiopulmonary bypass for poor outcomes in order to appropriately tailor medical care and for possible future trials.

Eligibility & Criteria

IRB #:
20-017388
Official Title:
Development of a Plasma Biomarker Risk Profile for Neonates Requiring Cardiopulmonary Bypass for Congenital Heart Disease
Study Phase:
Pilot
Eligible Age Range:
0 Months - 1 Months
Gender:
All
Study Categories:

Visit Criteria


Leader
Monique-Anne Maslak Gardner

Monique-Anne Maslak Gardner, MD